# PACS Group, Inc. (PACS) stock: price and valuation

URL: https://funkfolio.com/stock/PACS

> PACS Group, Inc. (PACS) trades at $48.54, is worth $7.7B, is priced at 27.6× earnings and scores 57/100. Valuation, financials and signals.

---

## PACS Group, Inc. (PACS)

PACS Group, Inc. (PACS) is a healthcare company (medical care facilities) based in the United States. The share price is $48.54, down 0.94% on the day, which values the company at $7.7B. Price as of 17 Nov 2026, 19:06 UTC, from Yahoo Finance.

### Key facts

- **Share price:** $48.54 −0.94% today
- **Market value:** $7.7B
- **P/E ratio:** 27.6× last 12 months
- **Forward P/E:** 17.0×
- **Funk Score:** 57/100
- **Sector:** Healthcare

Figures as of 17 Nov 2026, 19:06 UTC. Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

### PACS Group, Inc. in more detail

PACS trades at 27.6× its last twelve months' earnings, 17.0× next year's expected earnings, 1.4× sales.

Its Funk Score is 57 out of 100 (financial strength 4.0, profitability 3.3, growth 10.0, value 5.3, each out of 10).

In its favour: Strong Piotroski score. Worth checking: Low return on invested capital.

1 of the superinvestors tracked here hold PACS, including Chuck Royce (founder) (0.3% of the portfolio).

### Superinvestors holding PACS

1 of the investors tracked here report a position in their latest 13F filing.

- [Chuck Royce (founder) Royce & Associates](https://funkfolio.com/gurus/chuck-royce) 0.29% of portfolio · $32.2M · trimmed · Q3 2026

### Health Care companies of similar size

- [HealthEquity HQY](https://funkfolio.com/stock/HQY)
- [Corcept Therapeutics CORT](https://funkfolio.com/stock/CORT)
- [Rhythm Pharmaceuticals RYTM](https://funkfolio.com/stock/RYTM)
- [Alkermes ALKS](https://funkfolio.com/stock/ALKS)
- [Kiniksa Pharmaceuticals International KNSA](https://funkfolio.com/stock/KNSA)
- [ImmunityBio IBRX](https://funkfolio.com/stock/IBRX)
- [Cytokinetics CYTK](https://funkfolio.com/stock/CYTK)
- [ABIVAX ABVX](https://funkfolio.com/stock/ABVX)
- [Bausch + Lomb BLCO](https://funkfolio.com/stock/BLCO)
- [Amneal Pharmaceuticals AMRX](https://funkfolio.com/stock/AMRX)
- [Caris Life Sciences CAI](https://funkfolio.com/stock/CAI)
- [Immunovant IMVT](https://funkfolio.com/stock/IMVT)

Side by side: [PACS vs ALKS (PACS Group, Inc. vs Alkermes)](https://funkfolio.com/compare/alks-vs-pacs) [PACS vs KNSA (PACS Group, Inc. vs Kiniksa Pharmaceuticals International)](https://funkfolio.com/compare/knsa-vs-pacs) [PACS vs IBRX (PACS Group, Inc. vs ImmunityBio)](https://funkfolio.com/compare/ibrx-vs-pacs) [PACS vs CYTK (PACS Group, Inc. vs Cytokinetics)](https://funkfolio.com/compare/cytk-vs-pacs) [PACS vs ABVX (PACS Group, Inc. vs ABIVAX)](https://funkfolio.com/compare/abvx-vs-pacs)

[All health care companies by market value](https://funkfolio.com/companies/sector/health-care) [Largest companies in the United States](https://funkfolio.com/companies/country/united-states) [All stocks A–Z](https://funkfolio.com/stocks)

### PACS Group, Inc. (PACS): questions and answers

**What is PACS's P/E ratio?**

PACS Group, Inc. trades at 27.6× its last twelve months' earnings and 17.0× next year's expected earnings.

**What is PACS's PEG ratio?**

PACS Group, Inc.'s PEG ratio is 1.22 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

**What is PACS Group, Inc.'s market cap?**

PACS Group, Inc. is valued at $7.7B at a share price of $48.54.

**How fast is PACS Group, Inc. growing?**

Over the last three fiscal years PACS Group, Inc.'s revenue grew 29.7% a year and its earnings per share 6.8% a year.

**Does PACS pay a dividend?**

PACS Group, Inc. does not currently pay a regular dividend.

**Which famous investors own PACS?**

In their latest quarterly filings, Chuck Royce (founder) (0.3% of the portfolio) hold PACS. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

### Learn to read these numbers

[All stocks guides →](https://funkfolio.com/learn/stocks)

- [Altman Z-score: formula, zones and where it fails](https://funkfolio.com/learn/stocks/altman-z-score)

  The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- [Analyst price targets and ratings: what they mean](https://funkfolio.com/learn/stocks/analyst-price-targets)

  An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
- [Free cash flow and FCF yield explained](https://funkfolio.com/learn/stocks/free-cash-flow)

  Free cash flow is the cash a business generates from operations minus what it spends on equipment, buildings and other long-lived assets. Free-cash-flow yield divides that cash by the company's market value: $5 billion of free cash flow on a $100 billion company is a 5% yield. It is cash available to owners and lenders, not profit.

### Cite this page

Funkfolio, “PACS Group, Inc. (PACS) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/PACS

Underlying data: Yahoo Finance; company filings with the SEC.
